School of Medicine
Showing 201-300 of 497 Results
-
Elaheh Shaghaghian, MD
Visiting Instructor, Neurosurgery
BioElaheh Shaghaghian, MD, is a Clinical Research Scholar at Stanford University's Neurosurgery Department, where she investigates the efficacy of CyberKnife Radiosurgery with an interdisciplinary team. Skilled in problem-solving, Elaheh has a fervent passion for learning and applying new medical technologies.
She earned her MD from Shiraz University of Medical Sciences, focusing on advancing medical treatments through research. With experience in clinical research, data analysis, and interdisciplinary collaboration, she is dedicated to leveraging technology to enhance healthcare outcomes. -
Jacqueline Erin Shanley
Casual - Non Exempt, Psych/General Psychiatry and Psychology (Adult)
BioJacqueline is a psychology doctoral student in the PGSP-Stanford PsyD Consortium Program. She has multiple years of experience working in healthcare settings; she has both worked with patients who have autoimmune conditions and varying forms of dementia, alongside their families. Her research and clinical interests include health psychology, women's health, and relationships science.
-
Aditi Sharma
Basic Life Research Scientist, Pediatrics - General Pediatrics
Current Role at StanfordResearch Scientist
-
Sumana Shashidhar
Associate Director, Clinical Research Operations, Med/Stanford Center for Clinical Research
Current Role at StanfordAssociate Director - Clinical Research Operations
Stanford Center for Clinical Research -
Edward Sheen
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioDr. Edward Sheen is Chief Quality and Population Health Executive for L.A. Care. Serving more than 2.9 million members, L.A. Care is the largest publicly operated health plan in the country. As a public entity, its mission is to provide access to quality care for vulnerable and low-income communities and to elevate the safety net. Previously, he was Chief Population Health Officer, Senior Vice President for Health Catalyst and Chief Medical Officer, Market Development and Solution Design for Lumeris, a leading value-based care technology and services operator as well as 5.0 Star Medicare Advantage plan. He has worked with health systems and payers across the country to improve health outcomes, enhance patient experience, strengthen care provider engagement, reduce costs of care, and accelerate their journey towards accountable care. He is dedicated to achieving accessible, equitable, person-centered, and high-performing care for all.
Dr. Sheen’s experience has bridged the public, private, non-profit, and academic sectors and additionally includes work with Stanford University, the White House, U.S. Department of Defense, U.S. Department of Health and Human Services, California State Assembly, Kaiser Family Foundation, Blue Shield, California and American Medical Associations, and Genzyme. In 2014, he was one of 15 Americans appointed by President Obama a nonpartisan White House Fellow. He subsequently served as a Special Assistant to the Secretary of Defense and Defense Department senior health policy advisor and was a recipient of the Office of the Secretary of Defense Medal for Exceptional Public Service. Dr. Sheen was a Term Member of the Council on Foreign Relations. He currently serves on the National Advisory Council on the National Health Service Corps, which advises the Secretary of Health and Human Services. He is Adjunct Professor of Medicine and Global Health Faculty Fellow at Stanford. He has a long-standing active commitment to mentoring, teaching, and medical education.
Dr. Sheen completed his Internal Medicine and Gastroenterology training at Stanford, received his MD from the University of California, San Francisco, and earned his MBA and MPH through scholarships from Stanford Graduate School of Business and Harvard School of Public Health, where he was also a Harvard Kennedy School Center for Public Leadership Zuckerman Fellow. He graduated magna cum laude from Brown University with a B.A. in Public Policy and induction into Phi Beta Kappa.
